Cargando…
Advances in clinical outcomes: What we have learned during the COVID-19 pandemic
Our understanding of risk factors and interventions influencing outcomes from coronavirus disease 2019 (COVID-19) has continued to evolve, revealing advances emerging from hypotheses formed at the start of the pandemic. Epidemiologic studies have shown that asthma control, rather than a diagnosis of...
Autores principales: | Al-Musa, Amer, LaBere, Brenna, Habiballah, Saddiq, Nguyen, Alan A., Chou, Janet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704728/ https://www.ncbi.nlm.nih.gov/pubmed/34958811 http://dx.doi.org/10.1016/j.jaci.2021.12.775 |
Ejemplares similares
-
The resurgence of a neglected orthopoxvirus: Immunologic and clinical aspects of monkeypox virus infections over the past six decades
por: Al-Musa, Amer, et al.
Publicado: (2022) -
Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C)
por: Chou, Janet, et al.
Publicado: (2021) -
Remote Clinics and Investigations in Arrhythmia Services: What Have We Learnt During Coronavirus Disease 2019?
por: Honarbakhsh, Shohreh, et al.
Publicado: (2021) -
“We will have to learn to live with it”: Australian dentists’ experiences during the COVID-19 pandemic
por: Nahidi, Shizar, et al.
Publicado: (2022) -
COVID-19, long flights, and deep vein thrombosis: What we know so far
por: Krasiński, Zbigniew, et al.
Publicado: (2021)